JAG1 and colorectal carcinoma: In our study, we utilized the network pharmacological methodology to explore the pharmacological mechanism of the active components of AGS against CRC, and molecular docking and molecular dynamic simulation were used to investigate the docking pattern and capability between major active compounds of AGS and potential target proteins.